Hemetron AG

Chronic patients receive sub-optimal treatments today. Blood tests are necessary to personalize their treatment. These tests are limited to centralized facilities and can therefore not be performed as regularly as needed. Hemetron brings laboratory grade blood tests to the patient’s homes. The tests are based on a novel groundbreaking technology developed at ETH Zürich that can measure biomarker levels from a small drop of blood. Our first test under development quantifies inflammation levels and will help people with chronic inflammation to mitigate symptoms and to lower the risk for severe long-term diseases including cardiovascular diseases, Alzheimer’s, diabetes and cancer.